Broad Institute, Inc.

Other

US·SEC (Form 4)

Verve Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by Broad Institute, Inc.. Director active across 1 companies, notably Verve Therapeutics, Inc.. Aggregated, 2 disclosures have been published. The latest transaction was filed on 21 June 2021 (J). Regulator: SEC (Form 4). The full history is free.

Declarations2 total

Executives●JVVerve Therapeutics, Inc.3SEC

B

Broad Institute, Inc.

0387,830 shares0

Common Stock

SEC:0000899243-21-025525·21 Jun 2021

SEC ↗

Executives●JVVerve Therapeutics, Inc.2SEC

B

Broad Institute, Inc.

0387,830 shares0